Crosstalk between Myc and activating transcription factor 2 (ATF2): Myc prolongs the half-life and induces phosphorylation of ATF2

被引:0
|
作者
Josef Miethe
Claudia Schwartz
Katja Wottrich
Dorit Wenning
Karl-Heinz Klempnauer
机构
[1] Institut für Biochemie,
[2] Westfälische-Wilhelms-Universität Münster,undefined
来源
Oncogene | 2001年 / 20卷
关键词
Myc; ATF2; phosphorylation; protein turnover;
D O I
暂无
中图分类号
学科分类号
摘要
Myc is a key regulator of cell growth, differentiation and apoptosis, and affects cell fate decisions by activating as well as by inhibiting the expression of cellular genes. Myc is a member of the basic region–helix–loop–helix–leucine zipper (b-HLH-Zip) class of transcription factors, which heterodimerizes with the Max protein and recognizes a consensus Myc binding motif. Stimulation of gene expression by Myc is thought to be mediated by direct binding of Myc–Max heterodimers to specific target genes. So far, only a few genes have been identified as direct binding targets of Myc, raising the possibility that Myc affects gene expression also by indirect mechanisms. In this work we present evidence that v-Myc encoded by the avian retrovirus MC29 stimulates activating transcription factor 2 (ATF2)-dependent transcription. Analysis of the effect of Myc on ATF2 shows that v-Myc prolongs the half-life of ATF2 and induces the phosphorylation of N-terminal sites of ATF2 (Thr-69 and Thr-71) which have previously been identified as the target sites of stress-activated protein kinases and implicated in the regulation of ATF2 activity. Taken together, our results suggest that v-Myc can affect gene expression indirectly by modulating the activity of ATF2.
引用
收藏
页码:8116 / 8124
页数:8
相关论文
共 50 条
  • [31] ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease
    Watson, Gregory
    Ronai, Ze'ev A.
    Lau, Eric
    PHARMACOLOGICAL RESEARCH, 2017, 119 : 347 - 357
  • [33] Pyruvate kinase M2 (PKM2) interacts with activating transcription factor 2 (ATF2) to bridge glycolysis and pyroptosis in microglia
    Li, Mengmeng
    Lu, Hongjian
    Wang, Xueyan
    Duan, Chengwei
    Zhu, Xiangyang
    Zhang, Yi
    Ge, Xin
    Ji, Feng
    Wang, Xueqin
    Su, Jianbin
    Zhang, Dongmei
    MOLECULAR IMMUNOLOGY, 2021, 140 : 250 - 266
  • [34] High Levels of Expression of Activating Transcription Factor-2 (ATF2) Are Associated with Worse Prognosis in Patients with Pancreatic Ductal Adenocarcinoma
    Liang, J. J.
    Wang, H.
    Bruggeman, R.
    Evans, D. B.
    Wang, H.
    LABORATORY INVESTIGATION, 2010, 90 : 362A - 362A
  • [35] A Cytoplasmic Negative Regulator Isoform of ATF7 Impairs ATF7 and ATF2 Phosphorylation and Transcriptional Activity
    Diring, Jessica
    Camuzeaux, Barbara
    Donzeau, Mariel
    Vigneron, Marc
    Rosa-Calatrava, Manuel
    Kedinger, Claude
    Chatton, Bruno
    PLOS ONE, 2011, 6 (08):
  • [36] Phosphorylation of ATF2 promotes odontoblastic differentiation via intrinsic HAT activity
    Zuo, Huanyan
    Xiao, Yao
    Han, Jiahao
    Lin, Yuxiu
    Tian, Cheng
    Zhang, Shu
    Yuan, Guohua
    Liu, Huan
    Chen, Zhi
    JOURNAL OF GENETICS AND GENOMICS, 2023, 50 (07) : 497 - 510
  • [37] High Levels of Expression of Activating Transcription Factor-2 (ATF2) Are Associated with Worse Prognosis in Patients with Pancreatic Ductal Adenocarcinoma
    Liang, J. J.
    Wang, H.
    Bruggeman, R.
    Evans, D. B.
    Wang, H.
    MODERN PATHOLOGY, 2010, 23 : 362A - 362A
  • [38] Phosphorylation of c-Jun and ATF2 in ventricular myocytes by endothelin and phenylephrine
    Clerk, A
    Sugden, PH
    IMMUNOLOGY, 1996, 89 : N141 - N141
  • [39] ATM-dependent phosphorylation of ATF2 is required for the DNA damage response
    Bhoumik, A
    Takahashi, S
    Breitweiser, W
    Shiloh, Y
    Jones, N
    Ronai, Z
    MOLECULAR CELL, 2005, 18 (05) : 577 - 587
  • [40] ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway
    Lo Iacono, Marco
    Monica, Valentina
    Vavala, Tiziana
    Gisabella, Mara
    Saviozzi, Silvia
    Bracco, Enrico
    Novello, Silvia
    Papotti, Mauro
    Scagliotti, Giorgio Vittorio
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (11) : 2598 - 2609